Breathtec BioMedical, Inc. is a listed company. Filings by its managers are published through SEDI. No insider at Breathtec BioMedical, Inc. has published a filing in the past twelve months. The most recent one dates from 24 October 2018.
Our records for Breathtec BioMedical, Inc. go back to 2016, with 2 purchases and 6 sales on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
17 of 17 declarations
Breathtec BioMedical, Inc. is a company focused on developing non-invasive diagnostic technologies for disease detection. It is listed on the Toronto Stock Exchange under the symbol XTSE.